Inferra AI / Company / PRVA
Privia Health Group, Inc.
PRVA · Health Care
Last earnings Aug 6, 2026
AI analysis
Q2 2025 · reported Aug 7, 2025
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
The event-summary record for this company carries no extracted figures, so the brief and charts cannot be drawn yet. The summary below and the held documents are the record for this event.
Guidance · company-stated
Direction: Raised
“htm EX-99.1 Document Exhibit 99.1 Privia Health Reports Second Quarter 2025 Financial Results Very Strong First Half Performance Across All Key Operating and Financial Metrics Implemented Providers +13.8% and Practice Collections +18.5% compared to 2Q 24 Guidance Raised to Above High End of Range for Practice Collections, GAAP Revenue, Platform Contribution and Adjusted EBITDA c ARLINGTON, VA August 7, 2025 Privia Health Group, Inc.”
“Key Operating and Non-GAAP Financial Metrics b d e For the Six Months Ended June 30, ($ in millions) 2025 2024 Change (%) Practice Collections $ 1,661.5 $ 1,435.7 15.7 % Care Margin b d $ 220.4 $ 194.7 13.2 % Platform Contribution b d $ 109.2 $ 92.1 18.5 % Adjusted EBITDA b d e $ 55.9 $ 41.9 33.3 % Updated FY 25 Guidance c d e f Privia Health raised its full-year 2025 outlook as follows FY 2024 Initial FY 2025 Guidance at 2.27.25 c Updated FY 2025 Guidance at 8.7.”
Classified from the release's primary full-year outlook statement.
Capital allocation
Second Quarter 2025 highlights include Continued strength in same-store growth and new provider additions, +13.8% versus 2Q 24 Practice Collections of $862.9 million, +18.5% versus 2Q 24 Adjusted EBITDA b d e of $29.0 million, +31.6% versus 2Q 24 Strong sales and business development pipeline and Cash of $390.1 million and no debt following $95 million deployed for IMS transaction in Arizona.
Debt On November 16, 2023, Privia Health Group, Inc.
Event summary
Reconciliations of non-GAAP adjusted net income and other non-GAAP financial measures are presented in tables near the end of this press release
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
Guidance & outlook
Direction: Raised
Revenue: “htm EX-99.1 Document Exhibit 99.1 Privia Health Reports Second Quarter 2025 Financial Results Very Strong First Half Performance Across All Key Operating and Financial Metrics Implemented Providers +13.8% and Practice Collections +18.5% compared to 2Q 24 Guidance Raised to Above High End of Range for Practice Collections, GAAP Revenue, Platform Contribution and Adjusted EBITDA c ARLINGTON, VA August 7, 2025 Privia Health Group, Inc.”
Margin: “Key Operating and Non-GAAP Financial Metrics b d e For the Six Months Ended June 30, ($ in millions) 2025 2024 Change (%) Practice Collections $ 1,661.5 $ 1,435.7 15.7 % Care Margin b d $ 220.4 $ 194.7 13.2 % Platform Contribution b d $ 109.2 $ 92.1 18.5 % Adjusted EBITDA b d e $ 55.9 $ 41.9 33.3 % Updated FY 25 Guidance c d e f Privia Health raised its full-year 2025 outlook as follows FY 2024 Initial FY 2025 Guidance at 2.27.25 c Updated FY 2025 Guidance at 8.7.”
Revenue — Raised (“Raised”)
“htm EX-99.1 Document Exhibit 99.1 Privia Health Reports Second Quarter 2025 Financial Results Very Strong First Half Performance Across All Key Operating and Financial Metrics Implemented Providers +13.8% and Practice Collections +18.5% compared to 2Q 24 Guidance Raised to Above High End of Range for Practice Collections, GAAP Revenue, Platform Contribution and Adjusted EBITDA c ARLINGTON, VA August 7, 2025 Privia Health Group, Inc.”
Margin — Raised (“raised”)
“Key Operating and Non-GAAP Financial Metrics b d e For the Six Months Ended June 30, ($ in millions) 2025 2024 Change (%) Practice Collections $ 1,661.5 $ 1,435.7 15.7 % Care Margin b d $ 220.4 $ 194.7 13.2 % Platform Contribution b d $ 109.2 $ 92.1 18.5 % Adjusted EBITDA b d e $ 55.9 $ 41.9 33.3 % Updated FY 25 Guidance c d e f Privia Health raised its full-year 2025 outlook as follows FY 2024 Initial FY 2025 Guidance at 2.27.25 c Updated FY 2025 Guidance at 8.7.”
Classified from the release's primary full-year outlook statement.
Capital allocation
Second Quarter 2025 highlights include Continued strength in same-store growth and new provider additions, +13.8% versus 2Q 24 Practice Collections of $862.9 million, +18.5% versus 2Q 24 Adjusted EBITDA b d e of $29.0 million, +31.6% versus 2Q 24 Strong sales and business development pipeline and Cash of $390.1 million and no debt following $95 million deployed for IMS transaction in Arizona.
SEC original ↗Privia Health Group, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
Debt On November 16, 2023, Privia Health Group, Inc.
SEC original ↗Privia Health Group, Inc. — 10-Q Quarterly report10-QAug 6, 2026
, and Privia Health, LLC, as borrower, (collectively, the Privia Parties ) entered into a credit agreement (the Revolving Credit Agreement ) with Wells Fargo Bank, National Association, as issuing lender, and certain other lenders, pursuant to which the Privia Parties established a $ 125 million five-year senior secured revolving credit facility (the Revolving Credit Facility ).
SEC original ↗Privia Health Group, Inc. — 10-Q Quarterly report10-QAug 6, 2026
The Revolving Credit Agreement includes a commitment fee on the unused Revolving Credit Facility that ranges from 0.20 % to 0.30 % ( 0.20 % per annum at year end) depending on the consolidated leverage ratio.
SEC original ↗Privia Health Group, Inc. — 10-Q Quarterly report10-QAug 6, 2026
The facility generally may be used for capital expenditures, expenses related to transactions and general corporate purposes.
SEC original ↗Privia Health Group, Inc. — 10-Q Quarterly report10-QAug 6, 2026
As of June 30, 2026, no amounts were outstanding under the Revolving Credit Facility.
SEC original ↗Privia Health Group, Inc. — 10-Q Quarterly report10-QAug 6, 2026
Strategy & priorities
Forward-looking statements can be identified by words such as aims, anticipates, assumes, believes, estimates, expects, forecasts, future, intends, likely, may, outlook, plans, potential, projects, seeks, strategy, targets, trends, will, would, could, should, and variations of such terms and similar expressions and references to guidance, although some forward-looking statements may be expressed differently.
SEC original ↗Privia Health Group, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
These forward-looking statements, which are subject to risks, uncertainties and assumptions about us, may include projections of our future financial performance, our anticipated growth strategies and anticipated trends in our business.
SEC original ↗Privia Health Group, Inc. — 10-Q Quarterly report10-QAug 6, 2026
On March 2, 2023, the Company entered into a strategic alignment agreement (the Equity Alignment Agreement ) with ChoiceHealth, Inc.
SEC original ↗Privia Health Group, Inc. — 10-Q Quarterly report10-QAug 6, 2026
Risks & headwinds
Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results may differ materially from past results and those anticipated, estimated or projected.
SEC original ↗Privia Health Group, Inc. — Earnings release (8-K exhibit)EX-99Aug 7, 2025
Legal Proceedings 30 Item 1A.
SEC original ↗Privia Health Group, Inc. — 10-Q Quarterly report10-QAug 6, 2026
These forward-looking statements, which are subject to risks, uncertainties and assumptions about us, may include projections of our future financial performance, our anticipated growth strategies and anticipated trends in our business.
SEC original ↗Privia Health Group, Inc. — 10-Q Quarterly report10-QAug 6, 2026
We are currently involved in, and may in the future become involved in, legal proceedings, claims, investigations and regulatory inquiries in the ordinary course of our business, including medical malpractice claims.
SEC original ↗Privia Health Group, Inc. — 10-Q Quarterly report10-QAug 6, 2026
Although the results of these legal proceedings, claims, investigations and inquiries cannot be predicted with certainty, we do not believe that the final outcome of any matters that we are currently involved in are reasonably likely to have a material adverse effect on our business, financial condition or results of operations.
SEC original ↗Privia Health Group, Inc. — 10-Q Quarterly report10-QAug 6, 2026
Competitors
Competitors & peers
Same GICS sector — classification peers, not declared competitors
Filings
34 documents- Q2 2026
- 8-KPRVA
Aug 18, 2026
- 8-KPRVA
- 10-QPRVA
- 8-KPRVA
- Q1 2026
- 8-KPRVA
May 22, 2026
- 8-KPRVA
- EX-99PRVA
- 10-QPRVA
- Q4 2025
- 10-KPRVA
Feb 27, 2026
- 8-KPRVA
Feb 26, 2026
- Q3 2025
- 8-KPRVA
- 8-KPRVA
- 10-QPRVA
- 8-KPRVA
Oct 28, 2025
- Q2 2025
- 8-KPRVA
Sep 23, 2025
- EX-99PRVA
Sep 23, 2025
- 8-KPRVA
Aug 29, 2025
- EX-99PRVA
Aug 29, 2025
- 8-KPRVA
- 10-QPRVA
- 8-KPRVA
- EX-99PRVA
- Q1 2025
- 8-KPRVA
May 22, 2025
- 8-KPRVA
- 10-QPRVA
- Q4 2024
- 8-KPRVA
- 8-KPRVA
Feb 27, 2025
- 10-KPRVA
Feb 27, 2025
- 8-KPRVA
Jan 13, 2025
- Q3 2024
- 8-KPRVA
- 10-QPRVA
- Q2 2024
- 8-KPRVA
- 10-QPRVA
- 8-KPRVA
Earnings releases
9 documentsPresentations
0 documentsNo presentations for Privia Health Group, Inc. are held in this edition of the library.
Transcripts
0 documentsNo transcripts for Privia Health Group, Inc. are held in this edition of the library.
See also the earnings calendar for every tracked company’s next earnings date.